Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2013
04/11/2013WO2013050405A1 Methods and pharmaceutical compositions for the treatment of th2 mediated diseases
04/11/2013WO2013050387A1 Sensor module and electrode for a sensor module
04/11/2013WO2013050383A2 In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy
04/11/2013WO2013050280A1 Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
04/11/2013WO2013050249A1 METHOD FOR DETECTING Aß-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE
04/11/2013WO2013050248A1 Method for diagnosing alzheimer's disease (ad)
04/11/2013WO2013049891A1 Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads
04/11/2013WO2013025322A3 Marker-based prognostic risk score in liver cancer
04/11/2013WO2013024024A3 Quality assessment of induced pluripotent cells by referring to splicing signatures of pluripotency
04/11/2013WO2013019290A3 Immature reticulocyte fraction reference control and related methods
04/11/2013WO2013016114A3 Enzymatic cleavage based lateral flow assays
04/11/2013WO2013015717A3 Method for determining the activity of a proteolytic enzyme (variants), device for the implementation of same and diagnostic method
04/11/2013WO2013013220A3 Photonic blood typing
04/11/2013WO2013012924A3 Engineered microbe-targeting molecules and uses thereof
04/11/2013WO2013010176A3 Pharmacophores for amyloid fibers involved in alzheimer's disease
04/11/2013WO2013010085A3 Diagnosis, prognosis, and treatment of kidney disease
04/11/2013WO2013008170A3 Gas sensing apparatus
04/11/2013WO2013006495A3 Methods of predicting prognosis in cancer
04/11/2013WO2013006000A3 Method for detecting breast cancer using respiratory gas
04/11/2013WO2013003812A3 Analyte detection using near-infrared fluorophores
04/11/2013WO2012177106A3 Probe for ifret and usage of same
04/11/2013WO2012176129A3 Matrix permittivity determination
04/11/2013WO2012172151A3 Isolated antigen peptide derived from s100-beta protein, identification method and use thereof in the prevention, treatment, diagnosis and/or monitoring of type 1 diabetes
04/11/2013WO2012154983A3 Systems and methods for anti-pax8 antibodies
04/11/2013WO2012020308A3 Pancreatic duct progenitor cells and microrna obtained therefrom for use in tissue regeneration
04/11/2013US20130091591 Artery- and vein-specific proteins and uses therefor
04/11/2013US20130090550 Methods of identifying patients with ovarian epithelial neoplasms based on high-resolution mass spectrometry
04/11/2013US20130090456 Methods for identifying immunobinders of cell-surface antigens
04/11/2013US20130090376 Antibodies to tumor associated proteins
04/11/2013US20130090370 Apoptosis inducer for cancer cell
04/11/2013US20130090329 Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
04/11/2013US20130090263 Fluorescent proteins, nucleic acids encoding them and methods for making and using them
04/11/2013US20130090260 Multiplexed Assay Using Spectrally-Encoded Solid Support Matrices
04/11/2013US20130090256 Biomarkers for early detection of ovarian cancer
04/11/2013US20130090251 Tumour Markers
04/11/2013US20130090249 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4 ligands, and uses thereof
04/11/2013US20130089932 FET Sensor and Methods for Detecting Melamine
04/11/2013US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof
04/11/2013US20130089921 Device for detecting properties of chemical and/or biological fluids
04/11/2013US20130089909 Binding a target substance
04/11/2013US20130089884 Protein Modification from the Oxidation of Clickable Polyunsaturated Fatty Acid Analogs
04/11/2013US20130089878 Glp-1 receptor agonist bioassay
04/11/2013US20130089877 THE NOVEL ABETA22(pE)-42 PEPTIDE THAT BINDS TO AMYLOID-BETA ANTIBODY SPECIFICALLY IN BLOOD AND PHARMACEUTICAL COMPOSITION FOR THE DIAGNOSIS OF DEMENTIA DISEASE CONTAINING THE SAME AS AN ACTIVE INGREDIENT
04/11/2013US20130089876 Capillary biosensor system and its method of use
04/11/2013US20130089875 PEGylated insulin-like-growth-factor assay
04/11/2013US20130089874 Recirculating fluidic network and methods for using the same
04/11/2013US20130089873 Monoclonal antibodies against her2 antigens, and uses therefor
04/11/2013US20130089869 Methods For and Uses of Mechanical Stiffness Profiling of Cancer Cells
04/11/2013US20130089868 Assay for Detection of Transient Intracellular CA2+
04/11/2013US20130089856 Method for in vitro detection of ataxia telangiectasia healthy carriers and related kit
04/11/2013US20130089854 Kit for dot immunogold directed filtration assay and use thereof
04/11/2013US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
04/11/2013US20130089557 Antibody specifically binding to epitope in sema domain of c-met
04/11/2013US20130089536 Pharmaceutical composition to prevent and treat alzheimer's disease comprising gcp ii mutant
04/11/2013US20130089474 Apparatus for testing a liquid specimen
04/11/2013US20130089467 Generation device, generation method, antibody chip, computer program and non-transitory computer-readable medium
04/11/2013US20130089465 Micromechanical sensor system having super hydrophobic surfaces
04/11/2013US20130088358 Fastener testing device
04/11/2013US20130086976 Apparatus for measuring concentration of co2 for vehicle
04/11/2013US20130086975 Techniques For Calculating Gas Concentrations in a Fluid Environment
04/11/2013DE102011118002B9 Vorrichtung und Verfahren zum Sammeln von Partikeln Device and method for collecting particulates
04/11/2013DE102011115480A1 Substrate useful for chemiluminescence detection using enhancers or enhanced chemiluminescence reactions on carriers, comprises luminophore luminol, where e.g. enhancer concentration is optimized with respect to luminol concentration
04/11/2013DE102011084286A1 Verfahren und vorrichtung zur quantifizierung einer schädigung eines hautgewebeschnittes Method and device for quantification of damage of skin tissue-section
04/11/2013DE102011054334A1 Verfahren zur Bestimmung der Interaktion zwischen einem Polynucleotid und Blutplättchenfaktor 4 Method for determining the interaction between a polynucleotide and platelet factor 4
04/11/2013DE102011005254B4 Vorrichtung und Verfahren zur Untersuchung von Probenflüssigkeiten Apparatus and method for investigation of sample fluids
04/11/2013DE102004005086B4 Vorrichtung zum Messen der Konzentration einer lichtabsorbierenden Substanz in Blut Apparatus for measuring the concentration of a light absorbing substance in blood
04/11/2013CA2851314A1 Predicting tumor response to anti-erbb3 antibodies
04/11/2013CA2851261A1 Myosin binding protein-c for use in methods relating to diastolic heart failure
04/11/2013CA2851230A1 Prognostic method for diabetes
04/11/2013CA2850930A1 Methods and devices for assessing risk to a putative offspring of developing a condition
04/11/2013CA2850843A1 Method for detecting a.beta.-specific antibodies in a biological sample
04/11/2013CA2850840A1 Method for diagnosing alzheimer's disease (ad)
04/11/2013CA2850696A1 Monoclonal antibody specifically recognizing asparagine synthetase
04/11/2013CA2850686A1 Phosphospecific antibodies recognising tau
04/11/2013CA2850668A1 Srm/mrm assay for the ephrin type-a receptor 2 protein
04/11/2013CA2850667A1 Srm/mrm assay for the receptor tyrosine-protein kinase erbb-4 protein (her4)
04/11/2013CA2850231A1 Method and apparatus for using velocity profile measurements in recovering bitumen from a coarse tailings line
04/11/2013CA2849335A1 Methods and systems for identifying and treating anti-progestin sensitive tumors
04/11/2013CA2841867A1 Dye conjugated peptides for fluorescent imaging
04/11/2013CA2789052A1 Methods and systems for investigation of compositions of ontological subjects
04/10/2013EP2579043A1 Detection method
04/10/2013EP2579042A1 Method for detecting Aß-specific antibodies in a biological sample
04/10/2013EP2579041A1 Rapid detection tool and kit for premature rupture of fetal membrane taking icam-1 as detection index
04/10/2013EP2579040A2 Qualitative and quantitative analytical method for analyzing the activity type of an enzyme that is activated by proteolysis
04/10/2013EP2579039A1 Neuropeptide release assay for sodium channels
04/10/2013EP2579038A2 Biomarkers for multiple sclerosis
04/10/2013EP2579037A1 Method for testing the severity of an illness
04/10/2013EP2579036A1 Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
04/10/2013EP2579035A1 Urine analysis method, device thereof, program used in urine analysis method, and storage medium thereof
04/10/2013EP2579031A1 Biosensor for measuring blood component and hematocrit.
04/10/2013EP2579026A2 Optical equipment and registration method
04/10/2013EP2579025A1 Near field-enhanced fluorescence sensor chip
04/10/2013EP2579024A1 Device for detecting biomolecule and method for detecting biomolecule
04/10/2013EP2579023A1 Surface plasmon resonance fluorescence analysis device and surface plasmon resonance fluorescence analysis method
04/10/2013EP2579022A1 Metal microparticle composite and method for producing the same
04/10/2013EP2579020A1 Gel particle measurement device
04/10/2013EP2579019A1 Cell sorter, cell sorting system, and cell sorting method
04/10/2013EP2579018A1 Detection system and humidity detection method for detecting volatile organic compound
04/10/2013EP2578699A1 Methods for detection of risk of obesity and risk of onset of diabetes
04/10/2013EP2578693A1 Method for detecting bacteria